Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1350 of 5804
-
New hope for low blood counts after CAR T-Cell therapy?
Disease control Recruiting nowTo look at the safety and effectiveness of emapalumab for the treatment of prolonged severe cytopenia in participants with LBCL who receive CART.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Artificial intelligence reads CT scans to forecast pancreatic cancer prognosis
Diagnosis CompletedThis study describes the development and validation of a deep learning prediction model, which extracts deep learning features from preoperative enhanced CT scans and analyzes postoperative pathological specimens of pancreatic cancer patients. The aim is to predict patient progno…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Experimental combo aims to tackle Hard-to-Treat prostate cancer
Disease control Recruiting nowCarrying out clinical trials of salbutamol hydrochloride combined with immunotherapy and castration for the treatment of prostate cancer is of great significance. Firstly, it can verify the efficacy and safety of this combination in the treatment of prostate cancer, providing a s…
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug cocktail targets tough KRAS G12D cancers in early trial
Disease control OngoingThe study is being conducted to evaluate the safety, tolerability, and efficacy of HRS-4642 in combination with antitumor medicine in patients with advanced solid tumors harboring KRAS G12D mutation.
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 19:02 UTC
-
Could brain tumor patients stop seizure meds sooner?
Disease control Recruiting nowLevetiracetam is the commonly preferred anti-seizure medicine in patients with brain tumors. This drug has reduced the risk of seizure events occurring but is associated with a risk of side effects such as increased headache, drowsiness, loss of muscle coordination, and psycholog…
Phase: PHASE3 • Sponsor: Tata Memorial Centre • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for chinese patients with severe transplant complication: ruxolitinib trial launches
Disease control Recruiting nowThe purpose of this study is to assess the efficacy and safety of ruxolitinib therapy in Chinese adults and adolescents (≥ 12 years old) with Grade II-IV steroid-refractory acute graft versus host disease (SR-aGvHD).
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for Hard-to-Treat cancers: first human trial begins
Disease control Recruiting nowA First-in-Human, Open Label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of FZ-AD005 in Patients with Advanced Solid Tumors.
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Immune check could stop virus after lung transplants
Disease control Recruiting nowThe purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
AI stethoscope could spot heart valve trouble in minutes
Diagnosis Recruiting nowThe goal of this observational study is to evaluate accuracy of portable electronic stethoscope and machine learning-based diagnostic algorithms for detecting the disease in people with valvular heart disease and healthy controls. The main question it aims to answer is: Is porta…
Sponsor: The University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Freezing heart tissue during surgery could stop atrial fibrillation
Disease control Recruiting nowThe study involves endocardial cryoablation of the left and/or right atrium of the heart using the CoolCryo system as an adjunct to mitral valve surgery, with the aim of eliminating atrial fibrillation (AF), which is a common sequelae of mitral valve defects and is associated wit…
Sponsor: Medinice S.A. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a simple score shorten blood thinner use after a heart attack?
Disease control Recruiting nowMonotherapy with a P2Y12 inhibitor after a minimum period of DAPT following percutaneous coronary intervention (PCI) is an emerging de-escalation antiplatelet strategy in recent years. However, the optimal timing for de-escalating DAPT in ACS patients undergoing PCI remains debat…
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:32 UTC
-
Could a common antidepressant supercharge lung cancer treatment?
Disease control Recruiting nowClinical Trial The objective of this clinical trial is to determine whether antidepressant medications, such as olanzapine, in combination with immune checkpoint inhibitors are more effective than the use of immune checkpoint inhibitors alone. The main questions it aims to answe…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug aims to slow kidney damage in diabetes and rare diseases
Disease control Recruiting nowThis is an adaptive prospective, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of WAL0921 in subjects with glomerular kidney disease and proteinuria, including diabetic nephropathy and rar…
Phase: PHASE2 • Sponsor: Walden Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Brain training program aims to restore cognitive function in veterans with long COVID
Symptom relief ENROLLING_BY_INVITATIONCognitive dysfunction, psychiatric symptoms, functional impairment, and disability following COVID-19 negatively impact Veterans' community functioning and quality of life, contribute to significant human suffering, and are costly to VHA. Rehabilitation is a critical priority for…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New combo therapy aims to tackle tough lymphoma
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of Pembrolizumab in combination with Olaparib in participants with relapsed/refractory Peripheral T-cell Lymphoma (PTCL). The study mainly aims to evaluate: * objective response rate (ORR) as per Cheson resp…
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jun 26, 2026 14:13 UTC
-
New nasal spray COVID booster shows promise in early trial
⭐️ VACCINE ⭐️ CompletedA clinical trial to evaluate the safety, reactogenicity, and immunogenicity of MPV/S-2P administered intranasally to adults who have previously received a primary series and at least one booster with an authorized or licensed mRNA SARS-CoV-2 parenteral vaccine. The primary object…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 22, 2026 00:00 UTC
-
New High-Tech glasses could help kids with low vision read better
Symptom relief CompletedThis clinical trial aims to assess the efficacy and safety of the Shilangqing Smart Reading Aid, a head-mounted device integrating XR and AI technologies, in improving reading performance and quality of life among children with low vision. The study employs a multicenter, randomi…
Phase: NA • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Which anesthesia is safer for stroke surgery? new study aims to find out
Disease control Recruiting nowThe study is planned to evaluate the effectiveness and safety of two types of anesthesia (regional and general) for carotid endarterectomy in 100 patients with acute stage of stroke: 50 patients will be operated under regional anesthesia and the remaining 50 patients under genera…
Phase: NA • Sponsor: Pirogov Russian National Research Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New model aims to treat opioid use disorder in mothers right at their baby's hospital bedside
Disease control Recruiting nowThe purpose of this study is to address the gap in maternal OUD treatment and infant neonatal opioid withdrawal syndrome care. The research team will develop a treatment model and a set of strategies to provide evidence-based OUD treatment to postpartum mothers in NICUs. First, …
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could steroids save sight in parasitic eye disease?
Disease control Recruiting nowThe Parasitic Ulcer Treatment Trial (PUTT) is a multi-center, parallel-group, randomized clinical trial. The purpose of this study is to determine whether including topical corticosteroids in a regimen for acanthamoeba keratitis (AK) will improve vision. Patients presenting to al…
Phase: PHASE3 • Sponsor: Jeremy Keenan, MD, MPH • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC